Author

M. Milevskiy

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Approach:statistical model· 2 Approach:benchmark study· 1 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

J. E. Visvader· 2 shared M. Brown· 2 shared A. J. Kueh· 1 shared A. Jeyasekharan· 1 shared A. Shewan· 1 shared A. Stone· 1 shared A. Strasser· 1 shared A. T. Papenfuss· 1 shared

Activity by Year

2018-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. E. Visvader

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Towards resolution of the intron retention paradox in breast cancer

J. S. Shah, M. Milevskiy, V. Petrova, A. Y. Au, J. J. L. Wong, J. E. Visvader, U. Schmitz, J. E. J. Rasko

This study investigates intron retention (IR) patterns in breast cancer and other cancers, finding that reduced IR in breast tumors correlates with poor prognosis and is linked to factors like cell proliferation and RBP expression.

bioRxiv · Mar 4, 2022Cancer Biology

Genome-wide in vivo CRISPR screens identify GATOR1 as a potent tumor suppressor in MYC-driven lymphomagenesis

M. A. Potts, S. Mizutani, Y. Deng, S. Vaidyanathan, K. Ting, G. Giner, S. Shruti, Y. Liao, S. Diepstraten, A. J. Kueh, M. Pal, G. Healey, L. Tai, Z. Wang, C. Koenig, , M. J. Herold

The paper identifies GATOR1 as a tumor suppressor in MYC-driven lymphomagenesis using in vivo CRISPR screens and shows its sensitivity to mTOR inhibitors.

bioRxiv · Feb 16, 2022 · PreprintCancer Biology

MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ Breast Cancer

M. Milevskiy, U. Gujral, C. Del Lama Marques, A. Stone, K. Northwood, L. Burke, J. Gee, K. Nephew, S. Clark, M. Brown

The paper shows that miR-196a is regulated by ER and serves as a prognostic biomarker in ER+ breast cancer.

bioRxiv · May 23, 2018Cancer Biology

MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal- like breast cancer

M. Milevskiy, G. Sandhu, A. Wronski, D. Korbie, B. Brewster, A. Shewan, S. Edwards, J. French, M. Brown

The paper identifies miR-29b-1-5p as a biomarker in basal-like breast cancer, showing its prognostic significance in BRCA1-deficient tumors.

bioRxiv · May 10, 2018Cancer Biology